½ÃÀ庸°í¼­
»óǰÄÚµå
1570677

¼¼°èÀÇ ÇコÄɾî¿ë 4D ¿µ»ó ½ÃÀå : ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº°, ±â¼úº° - ¿¹Ãø(2025-2030³â)

4D Imaging in Healthcare Market by Application (Cardiology, Neurology, Obstetrics & Gynecology), End User (Ambulatory Surgical Centers, Diagnostic Centers, Hospitals), Technology - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 191 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

ÇコÄɾî¿ë 4D ¿µ»ó ½ÃÀåÀº 2023³â¿¡ 82¾ï 1,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 93¾ï 5,000¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç, CAGR 14.79%·Î ¼ºÀåÇÒ Àü¸ÁÀ̰í, 2030³â¿¡´Â 215¾ï 8,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÇコÄɾî¿ë 4D ¿µ»óÀÇ ´ë»ó ¹üÀ§¿¡´Â ÇØºÎÇÐÀû ±¸Á¶ ¹× »ý¸®ÇÐÀû ÇÁ·Î¼¼½º¿¡ ´ëÇÑ ½Ç½Ã°£ ÀλçÀÌÆ®¸¦ Á¦°øÇÏ´Â °í±Þ ¿µ»ó ±â¼úÀÇ È°¿ëÀÌ Æ÷ÇԵǸç, ½Ã°£ Â÷¿øÀ» Ãß°¡ÇÏ¿© ±âÁ¸ÀÇ 3Â÷¿ø ¿µ»óÀ» ÃÊ¿ù ÀÖ½À´Ï´Ù. À̸¦ ÅëÇØ ¼ö¼ú °èȹ, Á¾¾ç ÃßÀû ¹× ÅÂ¾Æ ¸ð´ÏÅ͸µ°ú °°Àº ¿ëµµ ºÐ¾ß¿¡ ÇʼöÀûÀÎ ¿ªµ¿ÀûÀ̰í Á¤È®ÇÑ ½Ã°¢È­°¡ °¡´ÉÇÕ´Ï´Ù. 4D ¿µ»óÀÇ Çʿ伺Àº Áø´Ü ¹× Ä¡·áÀÇ ºÒÈ®½Ç¼ºÀ» ÁÙÀ̰í ȯÀÚ °á°úÀÇ °³¼±, Á¤¹Ðµµ Çâ»ó, ¼ö¼ú Á¤¹Ðµµ Çâ»óÀ¸·Î À̾îÁö´Â ´É·ÂÀ¸·Î ÀÎÇØ ¹ß»ýÇÕ´Ï´Ù. 4D ¿µ»óÀº ½ÉÀ庴ÇÐ, Á¾¾çÇÐ, »ê°úÇаú °°Àº ºÎ¹®¿¡¼­ Áß¿äÇÑ ¿ëµµ¸¦ ã¾ÒÀ¸¸ç Áø´Ü°ú ¼ö¼ú µÑ ´Ù Á¡Á¡ ´õ ¸¹ÀÌ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ¿äÀÎÀ¸·Î´Â ±â¼ú Áøº¸, ºñħ½ÀÀû Áø´Ü ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µÀÌ ÇÊ¿äÇÑ ¸¸¼º ÁúȯÀÇ ¸¸¿¬ µîÀÌ ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀΰøÁö´É°ú 4D ¿µ»ó ½Ã½ºÅÛÀÇ ÅëÇÕÀº À̹ÌÁö ºÐ¼®°ú ÀÚµ¿È­¸¦ °­È­ÇÕ´Ï´Ù. ±×·¯³ª ÀÌ ½ÃÀåÀº °í°¡ÀÇ ºñ¿ë, Àü¹®ÀûÀÎ ÈÆ·ÃÀÇ Çʿ伺, ±ÔÁ¦»óÀÇ Àå¾Ö¹° µî µµÀÔ ¼Óµµ¸¦ ¹æÇØÇÏ´Â °úÁ¦¿¡ Á÷¸éÇϰí ÀÖ½À´Ï´Ù. 4D ¿µ»óÀÌ ¿ø°Ý Áø´Ü ¹× ÁøÂûÀ» ÃËÁøÇÏ´Â ¿ø°Ý ÀÇ·á ±â´ÉÀÇ È®´ë¿¡´Â ºñÁî´Ï½º ±âȸ°¡ ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ½ÅÈï ½ÃÀå¿¡¼­´Â ÀÇ·á ÀÎÇÁ¶ó°¡ ±Þ¼ºÀåÇϰí ÀÖ¾î ±â¼úÀÌ º¸´Ù °¡±î¿öÁö¸é ¼ö¿ä°¡ ³ô¾ÆÁú °¡´É¼ºÀÌ ÀÖ½À´Ï´Ù. ±â¾÷Àº ´Ù¾çÇÑ ÀÇ·á ȯ°æ¿¡ ¸Â´Â ºñ¿ë È¿À²ÀûÀÎ 4D ¿µ»ó ¼Ö·ç¼ÇÀ» °³¹ßÇÔÀ¸·Î½á Çõ½ÅÀ» ÀÏÀ¸Å³ ¼ö ÀÖ½À´Ï´Ù. ÈÞ´ë¿ë ±â±âÀÇ ¼ÒÇüÈ­, È­»ó ÇØ»óµµÀÇ Çâ»ó, ó¸® ¼ÓµµÀÇ °í¼ÓÈ­ µî¿¡ ÁßÁ¡À» µÐ Á¶»ç°¡ ½Ç½ÃµÉ °¡´É¼ºÀÌ ÀÖ½À´Ï´Ù. °úÁ¦°¡ ÀÖ´Â °Í, 4D ¿µ»ó ½ÃÀåÀº ¿ªµ¿ÀûÀÌ¸ç ¼ºÀå °¡´É¼ºÀ» Áö´Ï°í ÀÖ½À´Ï´Ù. ±â¾÷Àº °æÀïÀ» À¯ÁöÇϱâ À§ÇØ ÀÇ·á Á¦°ø¾÷ü¿ÍÀÇ Àü·«Àû ÆÄÆ®³Ê½Ê°ú ±â¼ú ¹ßÀü¿¡ ÁÖ·ÂÇØ¾ß ÇÕ´Ï´Ù. ¿¬±¸°³¹ß¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ÅõÀÚ¿Í ±ÔÁ¦ Áؼö ¹× ½ÃÀå ¿ä±¸¿¡ ´ëÇÑ ³¯Ä«·Î¿î ´«ºûÀº ÀÌ·¯ÇÑ Çõ½ÅÀûÀÎ ÀÇ·á ºÎ¹®¿¡¼­ »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ °³Ã´ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023³â) 82¾ï 1,000¸¸ ´Þ·¯
¿¹Ãø³â(2024³â) 93¾ï 5,000¸¸ ´Þ·¯
¿¹Ãø³â(2030³â) 215¾ï 8,000¸¸ ´Þ·¯
CAGR(%) 14.79%

½ÃÀå ¿ªÇÐ : ±Þ¼ÓÈ÷ ÁøÈ­ÇÏ´Â ÇコÄɾî¿ë 4D ¿µ»ó ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

ÇコÄɾî¿ë 4D ¿µ»ó ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ðÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÅõÀÚ°áÁ¤, Àü·«Àû °áÁ¤ Á¤¹ÐÈ­, »õ·Î¿î ºñÁî´Ï½º ±âȸ ȹµæ¿¡ ´ëºñÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë°ú ±¸¸Å Ãß¼¼¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» ´õ¿í ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

Porter's Five Forces : ÇコÄɾî¿ë 4D ¿µ»ó ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ ¿öÅ©´Â ÇコÄɾî¿ë 4D ¿µ»ó ½ÃÀå °æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces ÇÁ·¹ÀÓ ¿öÅ©´Â ±â¾÷ÀÇ °æÀïÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ޱ¸ÇÏ´Â ¸íÈ®ÇÑ ±â¼úÀ» ¼³¸íÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» °áÁ¤ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®¸¦ ÅëÇØ ±â¾÷Àº ÀÚ»çÀÇ °­Á¡À» Ȱ¿ëÇÏ°í ¾àÁ¡À» ÇØ°áÇϰí ÀáÀçÀûÀÎ °úÁ¦¸¦ ÇÇÇÒ ¼ö ÀÖÀ¸¸ç º¸´Ù °­ÀÎÇÑ ½ÃÀå¿¡¼­ÀÇ Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ÇコÄɾî¿ë 4D ¿µ»ó ½ÃÀå¿¡¼­ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ÇコÄɾî¿ë 4D ¿µ»ó ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀÎ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ ¼³¸íÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¾ÕÀ¸·Î ¿¹»óµÇ´Â Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : ÇコÄɾî¿ë 4D ¿µ»ó ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

ÇコÄɾî¿ë 4D ¿µ»ó ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü µî ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀï Æ÷Áö¼Å´×À» ¹àÈú ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ½ÃÀå ÁýÁß, ¼¼ºÐÈ­ ¹× ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í °ø±Þ¾÷ü´Â °æÀïÀÌ Ä¡¿­ÇØÁö¸é¼­ ÀÚ½ÅÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : ÇコÄɾî¿ë 4D ¿µ»ó ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ÇコÄɾî¿ë 4D ¿µ»ó ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ Çà·ÄÀ» ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº °ø±Þ¾÷üÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±âÁØÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ¸Â´Â ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ °ø±Þ¾÷ü¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ºÎ¹®È­Çϰí Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ : ÇコÄɾî¿ë 4D ¿µ»ó ½ÃÀå¿¡¼­ ¼º°ø¿¡ ´ëÇÑ ±æÀ» ±×¸³´Ï´Ù.

ÇコÄɾî¿ë 4D ¿µ»ó ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ÀÇ Á¸À縦 °­È­ÇÏ·Á´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ´É·Â ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í °³¼±À» À§ÇØ ³ë·ÂÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ Á¢±Ù¹ýÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ üÁ¦¸¦ ¸¶·ÃÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â Á¾ÇÕÀûÀÎ ½ÃÀå ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æ¿¡ ´ëÇØ »ó¼¼È÷ °ËÅäÇÕ´Ï´Ù.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÎ¹®¿¡¼­ÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» ¼³¸íÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ°í ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» Á¶»çÇß½À´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, ¿¬±¸°³¹ß Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡µµ ´äº¯Çϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð ¹× ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ ¹× ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À² ¹× °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ÀÇ·á Áø´Ü°ú Ä¡·á °èȹ¿¡ À־ ¼±Áø ¿µ»ó ±â¼úÀÇ µµÀÔ Áõ°¡
      • Á¤È®ÇÑ Áø´Ü°ú °ü¸®¸¦ À§ÇØ °í±Þ ¿µ»ó Áø´ÜÀ» ÇÊ¿ä·Î ÇÏ´Â ¸¸¼º Áúȯ Áõ°¡
      • ÇコÄɾî¿ë ÀÎÇÁ¶ó ¹× ÇコÄɾî¿ë ¿µ»ó ¿¬±¸ °³¹ß¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡
    • ¾ïÁ¦¿äÀÎ
      • ÇコÄɾî¿ë 4D ¿µ»ó ±â¼úÀÇ µµÀÔ°ú À¯Áö¿¡ µå´Â ºñ¿ëÀº Áö¿ª¿¡ µû¶ó ´Ù¸¨´Ï´Ù.
    • ±âȸ
      • ¸ÂÃãÇü ÀÇ·á ¹× È¯ÀÚ °íÀ¯ÀÇ Ä¡·á ÇÁ·ÎÅäÄÝ¿¡¼­ÀÇ 4D ¿µ»óÀÇ ¿ëµµ È®´ë
      • ÀΰøÁö´É(AI)°ú ¸Ó½Å·¯´× ±â¼úÀÇ ÅëÇÕ
    • °úÁ¦
      • ±â¼úÀû º¹À⼺°ú ÄÄÇöóÀ̾𽺠¹®Á¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTLE ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå ÇコÄɾî¿ë 4D ¿µ»ó ½ÃÀå : ¿ëµµº°

  • ¼­¹®
  • ½ÉÀ庴ÇÐ
    • µ¿¸Æ°æÈ­Áõ
    • °ü»óµ¿¸ÆÁúȯ
    • ½É±Ù °ü·ù
  • ½Å°æÇÐ
    • ³úÁ¾¾çÀÇ ºÐ¼®
    • ½Å°æÅðÇ༺ Áúȯ
    • ³úÁ¹ÁßÀÇ Æò°¡
  • »êºÎÀΰú
    • ¼±ÃµÀÌ»ó
    • ÅÂ¾Æ ¸ð´ÏÅ͸µ
    • ŹÝÀÇ °Ç°­ Æò°¡
  • Á¾¾çÇÐ
    • ¾ÏÀÇ ½ºÅ×ÀÌÁö ºÐ·ù
    • Ä¡·á ¸ð´ÏÅ͸µ
    • Á¾¾ç °ËÃâ
  • Á¤Çü¿Ü°ú
    • °ñ¹Ðµµ ÃøÁ¤
    • °ñÀý Æò°¡
    • °üÀý ġȯ¼ú

Á¦7Àå ÇコÄɾî¿ë 4D ¿µ»ó ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • ¼­¹®
  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
    • °¡º­¿î ¿Ü°ú ¼ö¼ú
    • ¿Ü·¡ ¼ö¼ú
  • Áø´Ü¼¾ÅÍ
    • À̹ÌÁö ¼¾ÅÍ
    • º´¸®ÇÐ ¿¬±¸¼Ò
  • º´¿ø
    • »ç¸³º´¿ø
    • °ø¸³º´¿ø
  • ¿¬±¸±â°ü
    • ÀÓ»óÁ¶»ç
    • ½ÇÇèÁ¶»ç
  • Àü¹® Ŭ¸®´Ð
    • ½ÉÀ庴 Ŭ¸®´Ð
    • ½Å°æ°ú Ŭ¸®´Ð
    • Á¾¾ç°ú Ŭ¸®´Ð
    • Á¤Çü¿Ü°ú Ŭ¸®´Ð

Á¦8Àå ÇコÄɾî¿ë 4D ¿µ»ó ½ÃÀå : ±â¼úº°

  • ¼­¹®
  • ÄÄÇ»ÅÍ ´ÜÃþ ÃÔ¿µ
  • Àڱ⠰ø¸í ¿µ»ó
  • ¾çÀüÀÚ ¹æÃâ ´ÜÃþ ÃÔ¿µ
  • ÃÊÀ½ÆÄ
  • X¼± ¿µ»ó

Á¦9Àå ¾Æ¸Þ¸®Ä«ÀÇ ÇコÄɾî¿ë 4D ¿µ»ó ½ÃÀå

  • ¼­¹®
  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÇコÄɾî¿ë 4D ¿µ»ó ½ÃÀå

  • ¼­¹®
  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦11Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÇコÄɾî¿ë 4D ¿µ»ó ½ÃÀå

  • ¼­¹®
  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦12Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º(2023³â)
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼® ¹× Á¦¾È
AJY 24.10.31

The 4D Imaging in Healthcare Market was valued at USD 8.21 billion in 2023, expected to reach USD 9.35 billion in 2024, and is projected to grow at a CAGR of 14.79%, to USD 21.58 billion by 2030.

The scope of 4D imaging in healthcare involves utilizing advanced imaging technologies that provide real-time insights into anatomical structures and physiological processes, transcending traditional three-dimensional imaging by adding the dimension of time. This enables dynamic and precise visualization, crucial for applications such as surgical planning, tumor tracking, and fetal monitoring. The necessity of 4D imaging arises from its ability to reduce uncertainties in diagnosis and treatment, leading to improved patient outcomes, increased accuracy, and enhanced surgical precision. It finds significant application in cardiology, oncology, and obstetrics, among other fields, being used increasingly in both diagnostic and intraoperative settings. Key influencing growth factors include technological advancements, increasing demand for non-invasive diagnostic techniques, and the growing prevalence of chronic diseases that necessitate continuous monitoring. Moreover, the integration of artificial intelligence with 4D imaging systems presents opportunities for enhanced image analysis and automation. However, the market faces challenges such as high costs, the need for specialized training, and regulatory hurdles that can hinder the speed of adoption. Opportunities lie in expanding telemedicine capabilities, where 4D imaging could facilitate remote diagnosis and consultation. Furthermore, the burgeoning healthcare infrastructure in emerging markets could drive demand as technology becomes more accessible. Companies could innovate by developing cost-effective 4D imaging solutions tailored to diverse healthcare settings. Research efforts might focus on miniaturization for portable devices, improved image resolution, and faster processing capabilities. Despite its challenges, the 4D imaging market is dynamic with a robust potential for growth. Companies should focus on strategic partnerships with healthcare providers and technology advancements to stay competitive. Continuous investment in research and development, coupled with a keen eye on regulatory compliance and market needs, can help businesses exploit emerging opportunities in this transformative area of healthcare.

KEY MARKET STATISTICS
Base Year [2023] USD 8.21 billion
Estimated Year [2024] USD 9.35 billion
Forecast Year [2030] USD 21.58 billion
CAGR (%) 14.79%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving 4D Imaging in Healthcare Market

The 4D Imaging in Healthcare Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing adoption of advanced imaging technologies in medical diagnostics and treatment planning
    • Rising prevalence of chronic diseases requiring advanced imaging for accurate diagnosis and management
    • Growing investments in healthcare infrastructure and medical imaging R&D initiatives
  • Market Restraints
    • High cost of deploying and maintaining 4D imaging technology in healthcare varying across regions
  • Market Opportunities
    • Expanding applications of 4D imaging in personalized medicine and patient-specific treatment protocols
    • Integration with artificial intelligence (AI) and machine learning technology
  • Market Challenges
    • Technical complexity and compliance issues

Porter's Five Forces: A Strategic Tool for Navigating the 4D Imaging in Healthcare Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the 4D Imaging in Healthcare Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the 4D Imaging in Healthcare Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the 4D Imaging in Healthcare Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the 4D Imaging in Healthcare Market

A detailed market share analysis in the 4D Imaging in Healthcare Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the 4D Imaging in Healthcare Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the 4D Imaging in Healthcare Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the 4D Imaging in Healthcare Market

A strategic analysis of the 4D Imaging in Healthcare Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the 4D Imaging in Healthcare Market, highlighting leading vendors and their innovative profiles. These include Aidoc Medical, Arterys Inc., Butterfly Network Inc., Clarius Mobile Health, ContextVision, DeepSight Technology Inc., EchoNous Inc., Exact Imaging, HeartVista Inc., Infraredx Inc., iSono Health, Koios Medical, Median Technologies, Nanox Imaging Ltd., Oxipit AI, QT Imaging, Riverain Technologies, SuperSonic Imagine, TeraRecon Inc., and Therapixel SAS.

Market Segmentation & Coverage

This research report categorizes the 4D Imaging in Healthcare Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Application, market is studied across Cardiology, Neurology, Obstetrics & Gynecology, Oncology, and Orthopedics. The Cardiology is further studied across Atherosclerosis, Coronary Artery Disease, and Myocardial Perfusion. The Neurology is further studied across Brain Tumor Analysis, Neurodegenerative Diseases, and Stroke Assessment. The Obstetrics & Gynecology is further studied across Congenital Anomalies, Fetal Monitoring, and Placental Health Assessment. The Oncology is further studied across Cancer Staging, Treatment Monitoring, and Tumor Detection. The Orthopedics is further studied across Bone Density Measurement, Fracture Assessment, and Joint Replacement.
  • Based on End User, market is studied across Ambulatory Surgical Centers, Diagnostic Centers, Hospitals, Research Institutes, and Specialty Clinics. The Ambulatory Surgical Centers is further studied across Minor Surgical Procedures and Outpatient Surgery. The Diagnostic Centers is further studied across Imaging Centers and Pathology Labs. The Hospitals is further studied across Private Hospitals and Public Hospitals. The Research Institutes is further studied across Clinical Research and Experimental Research. The Specialty Clinics is further studied across Cardiology Clinics, Neurology Clinics, Oncology Clinics, and Orthopedic Clinics.
  • Based on Technology, market is studied across Computed Tomography, Magnetic Resonance Imaging, Positron Emission Tomography, Ultrasound, and X-Ray Imaging.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing adoption of advanced imaging technologies in medical diagnostics and treatment planning
      • 5.1.1.2. Rising prevalence of chronic diseases requiring advanced imaging for accurate diagnosis and management
      • 5.1.1.3. Growing investments in healthcare infrastructure and medical imaging R&D initiatives
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of deploying and maintaining 4D imaging technology in healthcare varying across regions
    • 5.1.3. Opportunities
      • 5.1.3.1. Expanding applications of 4D imaging in personalized medicine and patient-specific treatment protocols
      • 5.1.3.2. Integration with artificial intelligence (AI) and machine learning technology
    • 5.1.4. Challenges
      • 5.1.4.1. Technical complexity and compliance issues
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. 4D Imaging in Healthcare Market, by Application

  • 6.1. Introduction
  • 6.2. Cardiology
    • 6.2.1. Atherosclerosis
    • 6.2.2. Coronary Artery Disease
    • 6.2.3. Myocardial Perfusion
  • 6.3. Neurology
    • 6.3.1. Brain Tumor Analysis
    • 6.3.2. Neurodegenerative Diseases
    • 6.3.3. Stroke Assessment
  • 6.4. Obstetrics & Gynecology
    • 6.4.1. Congenital Anomalies
    • 6.4.2. Fetal Monitoring
    • 6.4.3. Placental Health Assessment
  • 6.5. Oncology
    • 6.5.1. Cancer Staging
    • 6.5.2. Treatment Monitoring
    • 6.5.3. Tumor Detection
  • 6.6. Orthopedics
    • 6.6.1. Bone Density Measurement
    • 6.6.2. Fracture Assessment
    • 6.6.3. Joint Replacement

7. 4D Imaging in Healthcare Market, by End User

  • 7.1. Introduction
  • 7.2. Ambulatory Surgical Centers
    • 7.2.1. Minor Surgical Procedures
    • 7.2.2. Outpatient Surgery
  • 7.3. Diagnostic Centers
    • 7.3.1. Imaging Centers
    • 7.3.2. Pathology Labs
  • 7.4. Hospitals
    • 7.4.1. Private Hospitals
    • 7.4.2. Public Hospitals
  • 7.5. Research Institutes
    • 7.5.1. Clinical Research
    • 7.5.2. Experimental Research
  • 7.6. Specialty Clinics
    • 7.6.1. Cardiology Clinics
    • 7.6.2. Neurology Clinics
    • 7.6.3. Oncology Clinics
    • 7.6.4. Orthopedic Clinics

8. 4D Imaging in Healthcare Market, by Technology

  • 8.1. Introduction
  • 8.2. Computed Tomography
  • 8.3. Magnetic Resonance Imaging
  • 8.4. Positron Emission Tomography
  • 8.5. Ultrasound
  • 8.6. X-Ray Imaging

9. Americas 4D Imaging in Healthcare Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific 4D Imaging in Healthcare Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa 4D Imaging in Healthcare Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Aidoc Medical
  • 2. Arterys Inc.
  • 3. Butterfly Network Inc.
  • 4. Clarius Mobile Health
  • 5. ContextVision
  • 6. DeepSight Technology Inc.
  • 7. EchoNous Inc.
  • 8. Exact Imaging
  • 9. HeartVista Inc.
  • 10. Infraredx Inc.
  • 11. iSono Health
  • 12. Koios Medical
  • 13. Median Technologies
  • 14. Nanox Imaging Ltd.
  • 15. Oxipit AI
  • 16. QT Imaging
  • 17. Riverain Technologies
  • 18. SuperSonic Imagine
  • 19. TeraRecon Inc.
  • 20. Therapixel SAS
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦